12.3 USD
-0.1 (-0.81%)
12.3 USD
0 (0%)
Taking everything into account, ANGO scores 2 out of 10 in our fundamental rating. ANGO was compared to 188 industry peers in the Health Care Equipment & Supplies industry. ANGO may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, ANGO is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
ANGO had negative earnings in the past year.
In the past year ANGO has reported a negative cash flow from operations.
ANGO had negative earnings in each of the past 5 years.
In multiple years ANGO reported negative operating cash flow during the last 5 years.
1.2 Ratios
ANGO has a Return On Assets of -12.08%. This is comparable to the rest of the industry: ANGO outperforms 59.04% of its industry peers.
With a decent Return On Equity value of -17.95%, ANGO is doing good in the industry, outperforming 62.23% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.08% | ||
| ROE | -17.95% | ||
| ROIC | N/A |
ROA(3y)-26.67%
ROA(5y)-18.08%
ROE(3y)-40.7%
ROE(5y)-27.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ANGO has a Gross Margin (54.15%) which is in line with its industry peers.
In the last couple of years the Gross Margin of ANGO has remained more or less at the same level.
ANGO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 54.15% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.95%
GM growth 5Y-1.07%
2. Health
2.1 Basic Checks
ANGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
ANGO has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ANGO has more shares outstanding
Compared to 1 year ago, ANGO has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.42 indicates that ANGO is not a great score, but indicates only limited risk for bankruptcy at the moment.
ANGO's Altman-Z score of 2.42 is fine compared to the rest of the industry. ANGO outperforms 65.96% of its industry peers.
ANGO has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
ANGO has a better Debt to Equity ratio (0.03) than 70.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.42 |
ROIC/WACCN/A
WACC8.62%
2.3 Liquidity
ANGO has a Current Ratio of 2.29. This indicates that ANGO is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.29, ANGO is in line with its industry, outperforming 42.02% of the companies in the same industry.
ANGO has a Quick Ratio of 1.38. This is a normal value and indicates that ANGO is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.38, ANGO is not doing good in the industry: 61.17% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.29 | ||
| Quick Ratio | 1.38 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 63.16% over the past year.
The Revenue has been growing slightly by 2.73% in the past year.
The Revenue has been growing slightly by 2.06% on average over the past years.
EPS 1Y (TTM)63.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.09%
Revenue 1Y (TTM)2.73%
Revenue growth 3Y-2.56%
Revenue growth 5Y2.06%
Sales Q2Q%12.18%
3.2 Future
The Earnings Per Share is expected to grow by 54.32% on average over the next years. This is a very strong growth
ANGO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.38% yearly.
EPS Next Y-124.4%
EPS Next 2Y6.71%
EPS Next 3Y70.91%
EPS Next 5Y54.32%
Revenue Next Year8.22%
Revenue Next 2Y6.68%
Revenue Next 3Y7.1%
Revenue Next 5Y7.38%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ANGO. In the last year negative earnings were reported.
Also next year ANGO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
ANGO's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ANGO is cheaper than 62.23% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 302.74 |
4.3 Compensation for Growth
ANGO's earnings are expected to grow with 70.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.71%
EPS Next 3Y70.91%
5. Dividend
5.1 Amount
ANGO does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
12.3
-0.1 (-0.81%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners94.25%
Inst Owner Change7.41%
Ins Owners6.51%
Ins Owner Change16.91%
Market Cap506.76M
Revenue(TTM)300.72M
Net Income(TTM)-32.10M
Analysts84
Price Target18.87 (53.41%)
Short Float %6.53%
Short Ratio4.88
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)46.03%
Min EPS beat(2)16.56%
Max EPS beat(2)75.49%
EPS beat(4)4
Avg EPS beat(4)69.76%
Min EPS beat(4)16.56%
Max EPS beat(4)122.62%
EPS beat(8)7
Avg EPS beat(8)48.61%
EPS beat(12)9
Avg EPS beat(12)24.28%
EPS beat(16)11
Avg EPS beat(16)1.41%
Revenue beat(2)2
Avg Revenue beat(2)3.95%
Min Revenue beat(2)2.06%
Max Revenue beat(2)5.83%
Revenue beat(4)4
Avg Revenue beat(4)2.25%
Min Revenue beat(4)0.41%
Max Revenue beat(4)5.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.45%
Revenue beat(12)4
Avg Revenue beat(12)-0.95%
Revenue beat(16)5
Avg Revenue beat(16)-1.23%
PT rev (1m)1.37%
PT rev (3m)1.37%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-11.11%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.23%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.98%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.69 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.83 | ||
| P/tB | 4.59 | ||
| EV/EBITDA | 302.74 |
EPS(TTM)-0.14
EYN/A
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS7.3
BVpS4.34
TBVpS2.68
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.08% | ||
| ROE | -17.95% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 54.15% | ||
| FCFM | N/A |
ROA(3y)-26.67%
ROA(5y)-18.08%
ROE(3y)-40.7%
ROE(5y)-27.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.95%
GM growth 5Y-1.07%
F-Score5
Asset Turnover1.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.64 | ||
| Cap/Depr | 16.39% | ||
| Cap/Sales | 1.36% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.29 | ||
| Quick Ratio | 1.38 | ||
| Altman-Z | 2.42 |
F-Score5
WACC8.62%
ROIC/WACCN/A
Cap/Depr(3y)17.4%
Cap/Depr(5y)17.38%
Cap/Sales(3y)1.57%
Cap/Sales(5y)1.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.09%
EPS Next Y-124.4%
EPS Next 2Y6.71%
EPS Next 3Y70.91%
EPS Next 5Y54.32%
Revenue 1Y (TTM)2.73%
Revenue growth 3Y-2.56%
Revenue growth 5Y2.06%
Sales Q2Q%12.18%
Revenue Next Year8.22%
Revenue Next 2Y6.68%
Revenue Next 3Y7.1%
Revenue Next 5Y7.38%
EBIT growth 1Y29.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year129.56%
EBIT Next 3Y68.76%
EBIT Next 5Y52.46%
FCF growth 1Y-144.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-627.94%
OCF growth 3YN/A
OCF growth 5YN/A
ANGIODYNAMICS INC / ANGO FAQ
What is the fundamental rating for ANGO stock?
ChartMill assigns a fundamental rating of 2 / 10 to ANGO.
What is the valuation status for ANGO stock?
ChartMill assigns a valuation rating of 1 / 10 to ANGIODYNAMICS INC (ANGO). This can be considered as Overvalued.
Can you provide the profitability details for ANGIODYNAMICS INC?
ANGIODYNAMICS INC (ANGO) has a profitability rating of 2 / 10.
What is the financial health of ANGIODYNAMICS INC (ANGO) stock?
The financial health rating of ANGIODYNAMICS INC (ANGO) is 3 / 10.